S SoftMaxx AI
Peptides · Evidence-graded entry

Argireline (acetyl hexapeptide-8): what the evidence shows

Argireline, evidence-graded: the best support is randomized human trials. Citations checked against PubMed records.

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-03 · Not medically reviewed · How we grade evidence

SoftMaxx AI sells no peptides and takes no vendor money.

The verdict · strongest evidence Human RCT

Human RCT A handful of small, short human trials exist: a 2002 study in the paper that introduced it (wrinkle depth reduced by up to 30% after 30 days; its emulsion is in the doses table), a 60-person randomized, placebo-controlled trial in Chinese subjects (4 weeks) reporting benefit, a three-arm randomized trial of 21 people in all in which a palmitoyl pentapeptide-4 cream did better than an acetylhexapeptide-3 cream, and a 19-person split-face study where the difference was not significant. The three-arm trial (21 people in all) reports acetylhexapeptide-3; CosIng lists acetyl hexapeptide-8; whether these are the same substance is not stated in the abstract.[1][2][3][4]

What Argireline is

Argireline is a six-amino-acid synthetic peptide, Ac-EEMQRR-NH2 [1]; a skin-penetration study names the same sequence acetyl hexapeptide-8 [6]. It is patterned on the N-terminal end of SNAP-25 and reported to inhibit vesicle docking by blocking formation of the ternary SNARE complex [2]. It was designed as a topical ingredient that mimics the action of botulinum toxins [1], and a 2025 review calls it widely used in topical formulations [7].

Claims vs. evidence

Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.

Common myths, checked

Doses used in studies (not a recommendation)

Each row comes from the cited source: a study dose, a safety-review limit or a registered trial's planned dose, as labelled. Where the abstract states no amount, the row says so. They are a record of what was reported, not dosing instructions, and nothing here says what you should take.

Studied inRouteAmount reportedHow oftenHow longnSource
Humanstopical (oil-in-water emulsion)emulsion described as containing 10% of the hexapeptide Study dosenot stated in abstract30 days—[1] healthy women volunteers (number not stated in abstract)
Humanstopical, applied to periorbital wrinkles (formulation not stated in abstract)concentration not stated in abstract Study dosetwice daily4 weeks60[2] 60 Chinese adults with periorbital wrinkles
Humanstopical cream to periorbital areanot stated in abstract Study dosetwice daily8 weeks21[3] 21 Indonesian women aged 26–55 in all, split across 3 arms
Humanstopical cosmetic use (safety ceiling)safe as used up to 0.005% (peptide) per CIR Expert Panel; data insufficient above that Safety-review limitn/an/a—[10] cosmetic consumers

Side effects and risks

Regulatory status (checked 2026-10-01 to 2026-10-03)

Report a side effect

If something went wrong after using a health product, tell a clinician. Report side effects to:

Common questions

Does Argireline work like Botox?

Human RCT It is patterned on part of SNAP-25 and, in lab tests, inhibited neurotransmitter release with much lower efficacy than botulinum toxin A. In human cadaver skin most of it washed off; about 0.2% of the applied dose was found in the outer layer, 0.01% in the epidermis and none in the dermis. Its human wrinkle trials are small and mixed: a 60-person trial was positive over 4 weeks, and a 19-person split-face study found no significant difference.[2][1][6][4]

Why is Argireline called Botox in a bottle?

In vitro (cells) Its developers designed it to mimic the action of botulinum toxins. In lab tests it inhibited neurotransmitter release with much lower efficacy than botulinum toxin A [1]. A 2025 review says whether it reaches nerve–muscle junctions is uncertain, and how it might inhibit muscle contraction when applied to skin is incompletely understood [7]. In human cadaver skin, none was detected in the dermis [6].[1][7][6]

Does Argireline cause sagging?

In vitro (cells) We found no human report of muscle weakness or sagging from topical argireline. In human cadaver skin none was detected in the dermis, and a 2025 review says whether it reaches nerve–muscle junctions is uncertain. A 19-person study reported no significant adverse events.[6][7][4]

How long does Argireline take to work?

The human studies cited here measured results after 28 days to 8 weeks. That is how long the studies ran, not a promise of results.[1][2][3][4][8]

References

Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.

  1. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci (2002). PubMed 18498523 DOI
  2. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol (2013). PubMed 23417317 DOI
  3. Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet. J Clin Aesthet Dermatol (2023). PubMed 36909866
  4. Investigating the effects of Argireline in a skin serum containing hyaluronic acids on skin surface wrinkles using the Visia® Complexion Analysis camera system for objective skin analysis. GMS Interdiscip Plast Reconstr Surg DGPW (2023). PubMed 38024099 DOI
  5. Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis. JMIR Dermatol (2024). PubMed 38376906 DOI
  6. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol (2015). PubMed 24754410 DOI
  7. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci (2025). PubMed 40565185 DOI
  8. Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin. Ann Dermatol (2019). PubMed 33911590 DOI
  9. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne) (2026). PubMed 41924746 DOI
  10. Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics. Int J Toxicol (2025). PubMed 40673537 DOI

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-03 · Not medically reviewed. Editorial standards · Evidence grading and update log.

Keep reading